Influence of Cytochrome CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Ambrisentan

Clinical trial NCT01311362 · COMPLETED

Trial details

NCT number: NCT01311362
Sponsor: Gerd Mikus
Status: COMPLETED
Study type: OBSERVATIONAL

Drug Interactions

Start date: 2011-03-01
Primary completion: 2012-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.